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Abstract
Objective:  to  estimate  the  prevalence  of  infection  by  respiratory  viruses  in  pediatric  patients
with cancer  and  acute  respiratory  infection  (ARI)  and/or  fever.
Methods:  cross-sectional  study,  from  January  2011  to  December  2012.  The  secretions  of
nasopharyngeal aspirates  were  analyzed  in  children  younger  than  21  years  with  acute  respiratory
infections.  Patients  were  treated  at  the  Grupo  em  Defesa  da  Crianc¸a Com  Câncer  (Grendacc)
and  University  Hospital  (HU),  Jundiaí,  SP.  The  rapid  test  was  used  for  detection  of  inﬂuenza
virus  (Kit  Biotrin,  Inc.  Ireland),  and  real-time  multiplex  polymerase  chain  reaction  (FTD,  Respi-
ratory  pathogens,  multiplex  Fast  Trade  Kit,  Malta)  for  detection  of  inﬂuenza  virus  (H1N1,  B),
rhinovirus,  parainﬂuenza  virus,  adenovirus,  respiratory  syncytial  virus,  human  parechovirus,
bocavirus,  metapneumovirus,  and  human  coronavirus.  The  prevalence  of  viral  infection  was
estimated  and  association  tests  were  used  (2 or  Fisher’s  exact  test).
Results:  104  samples  of  nasopharyngeal  aspirate  and  blood  were  analyzed.  The  median  age  was
12  ±  5.2  years,  51%  males,  68%  whites,  32%  had  repeated  ARIs,  32%  prior  antibiotic  use,  19.8%
cough,  and  8%  contact  with  ARIs.  A  total  of  94.3%  were  in  good  general  status.  Acute  lymphocytic
leukemia (42.3%)  was  the  most  prevalent  neoplasia.  Respiratory  viruses  were  detected  in  50
samples:  rhinoviruses  (23.1%),  respiratory  syncytial  virus  AB  (8.7%),  and  coronavirus  (6.8%).  Co-
detection  occurred  in  19%  of  cases  with  2  viruses  and  in  3%  of  those  with  3  viruses,  and  was  more
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frequent  between  rhinovirus  and  coronavirus  43.  Fever  in  neutropenic  patients  was  observed
in  13%,  of  which  four  (30.7)  were  positive  for  viruses.  There  were  no  deaths.
Conclusions: the  prevalence  of  respiratory  viruses  was  relevant  in  the  infectious  episode,  with
no increase  in  morbidity  and  mortality.  Viral  co-detection  was  frequent  in  patients  with  cancer
and  ARIs.
© 2014  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
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Infecc¸ões  respiratórias  virais  agudas  em  pacientes  pediátricos  com  câncer  em
tratamento  quimioterápico
Resumo
Objetivo:  estimar  a  prevalência  da  infecc¸ão  pelos  vírus  respiratórios  em  pacientes  pediátricos
com câncer  e  infecc¸ão  respiratória  aguda  (IRA)  e/ou  febre.
Métodos:  estudo  transversal,  de  janeiro  de  2011  a  dezembro  de  2012.  Foram  analisadas
secrec¸ões de  aspirado  da  nasofaringe  de  menores  de  21  anos,  com  quadro  respiratório  agudo,
atendidos  nos  hospitais  Grendacc  e  HU,  Jundiaí,  SP.  Foi  aplicado  o  teste  rápido  para  detecc¸ão  dos
vírus  inﬂuenza  (Kit  Biotrin®)  e  a  reac¸ão  em  cadeia  da  polimerase  multiplex  em  tempo  real  (Kit
multiplex/Fast  Trade®)  para  detecc¸ão  dos  vírus:  inﬂuenza  (A,  H1N1,  B),  rinovírus,  parainﬂuenza,
adenovírus  respiratório,  vírus  respiratório  sincicial,  parechovírus,  bocavírus,  metapneumovírus
humano  e  coronavírus  humano.  Foi  estimada  a  prevalência  de  infecc¸ão  viral  e  usados  testes  de
associac¸ão  (2 ou  teste  exato  de  Fisher).
Resultados:  foram  analisadas  104  amostras  de  aspirado  de  nasofaringe  e  sangue.  A  mediana
para a  idade  foi  12±5,2  anos;  masculino  (51%);  cor  branca  (68%);  IVAS  de  repetic¸ão  (32%);  uso
prévio  de  antibiótico  (32%);  tosse  (19,8%);  e  contato  com  IVAS  (8%).  Apresentavam-se  em  bom
estado  geral  94,3%  dos  pacientes.  A  leucemia  linfocítica  aguda  (42,3%)  foi  mais  prevalente.
Foram  detectados  vírus  respiratórios  em  50%  das  amostras:  rinovírus  (23,1%),  vírus  sincicial
respiratório  A/B  (8,7%)  e  coronavírus  (6,8%).  Ocorreu  codetecc¸ão  em  19%  entre  dois  vírus,  e
de  3%  entre  três  vírus,  sendo  a  mais  frequente  entre  rinovírus  e  coronavírus  43.  Febre  em
neutropênicos  foi  de  13%,  sendo  quatro  (30,7%)  com  vírus  positivo.  Não  houve  óbitos.
Conclusões: a  prevalência  de  vírus  respiratórios  foi  importante  no  episódio  infeccioso,  sem
aumento da  morbimortalidade.  As  codetecc¸ões  foram  frequentes  em  pacientes  com  câncer  e
IRA.
©  2014  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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In  both  developed  and  developing  countries,  respiratory  dis-
eases contribute  to  the  high  proportion  of  morbidity  and
mortality in  childhood.  It  is  estimated  that  25%  to  33%
of deaths  observed  in  children  younger  than  ﬁve  years
are caused  by  acute  respiratory  infections  (ARIs)  and  their
complications.1
In  Brazil,  the  expectation  of  new  cases  of  childhood
cancer is  9,300  cases  per  year  in  children  younger  than
15 years.  Among  these,  the  most  common  are  acute  lym-
phoblastic leukemia  (ALL)  and  central  nervous  system  (CNS)
tumor, followed  by  Hodgkin’s  lymphoma  (HL)  and  non-
Hodgkin’s lymphoma  (NHL).2 The  very  presence  of  the
disease may  be  a  factor  of  immunosuppression,  especially  in
ALL and  lymphomas.  Conversely,  treatment  with  chemother-
apy interferes  with  patients’  immune  response  capacity;3
infection  is  the  most  common  complication  associated  with
cancer and  its  treatment,  representing  the  main  cause  of
death rather  than  the  cancer  itself.2Acute  viral  respiratory  infections  are  the  most  common
causes of  febrile  episodes  in  children  younger  than  ﬁve
years, even  in  children  treated  with  antineoplastic  drugs.4,5
a
d
mMany  studies,  concepts,  and  protocols  are  well  estab-
ished for  the  management  of  fever  episodes  in  children  with
ancer. However,  there  are  still  doubts  regarding  the  true
ncidence and  the  role  of  viral  agents  in  respiratory  infec-
ions in  these  patients.6--10 Few  studies  have  been  published
n this  subject  in  the  past;  little  attention  has  been  given
n the  literature  to  new  viruses  such  as  human  coronavirus
hCoV) and  metapneumovirus  (hMPV  A/B)  in  immunocom-
romised pediatric  patients.10,11
This  study  aimed  to  determine  the  frequency  of  infection
aused by  respiratory  viruses  in  patients  younger  than  21
ears with  cancer  and  acute  respiratory  infection,  and  to
dentify whether  there  is  a  subgroup  that  has  severe  ARI.
ethods
n  observational,  cross-sectional  study  was  performed.
asopharyngeal aspirate  samples  from  patients  youngernd respiratory  symptoms  of  ARI  were  collected  using  a  stan-
ardized protocol.  The  clinical  records  were  collected  from
edical records  by  one  of  the  authors.
3 Benites  EC  et  al.
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Febrile oncology patient
Physician
Clinical triage
Request complete blood
count/consultation
-Blood culture (catheter and peripheral)
-Biochemical assessment (GOT, GPT,GGT)
-Urinalysis and urine culture
-Chest X-ray
-Complete blood count
-C-Reactive Protein
-Blood culture
Persistent fever for
more than 72 hours
No
Yes
-Blood culture for fungi
Medical/laboratory follow-up
repeating the triage tests
-Tomography
Medical
discharge
-Sinus X-ray
-Respiratory virus screening
-C-Reactive Protein
Laboratory assessment
Clinical follow-up after 24, 48, and 72 hrs,
repeating the following tests:
Figure  1  Selection  ﬂow  chart.
GOT, glutamic  oxaloacetic  transaminase;  GPT,  glutamic  pyruvic
transaminase; GGT,  gamma-glutamyl  transpeptidase.
s
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Patients  were  treated  in  the  children’s  hospital  Grendacc
HG) and  at  Hospital  Universitário  da  Faculdade  de  Medicina
e Jundiaí  (HUJ)  in  the  city  of  Jundiaí,  São  Paulo,  Brazil,
oth funded  by  the  Brazilian  Uniﬁed  Health  System  (Sistema
nico de  Saúde  -  SUS),  from  January  of  2011  to  December
f 2012.  The  HUJ  is  maternal  and  child  hospital,  a regional
eferral center  for  eight  cities,  and  offers  secondary  care  to
 population  of  approximately  900,000  inhabitants  of  Jundiaí
nd surrounding  area.  The  HG  is  a  day-hospital  and  referral
utpatient clinic  that  offers  assistance  for  cancer  treatment
n childhood.
The study  was  approved  by  the  Research  Ethics  Commit-
ee of  the  Faculdade  de  Medicina  de  Jundiaí  (N.  366/2009).
eﬁnitions
tudy  subjects:  cancer  patients  younger  than  21  years  with
cute respiratory  infections  (ARIs).  A  new  episode  of  ARI  was
onsidered when  there  was  an  interval  >  15  days  during  the
tudy period.
ARI: a  history  of  respiratory  prodrome,  with  at  least  one
r more  of  the  following  signs  or  symptoms:  fever,  coryza,
ough, sore  throat,  and/or  gastrointestinal  symptoms.
Fever:  at  least  one  episode  of  fever,  measured  or
eported, with  axillary  temperature  >  38 ◦C  (based  on  one
easurement) or  37.8 ◦C  (based  on  two  measurements  with
 1-hour  interval).
Hypothermia: temperature  <  37.5 ◦C.
Clinical  aspects:  good  overall  status,  sick,  and  toxemic.12
ood  overall  status  was  deﬁned  when  the  child,  at  the  ini-
ial appointment,  showed  no  change  in  overall  appearance
nd was  active,  without  distress  or  pain.  The  patient  was
onsidered sick  when  he/she  was  irritable,  anxious,  or  had
 fatigued  or  suffering  appearance.
Toxemic:  patient  had  difﬁculty  breathing,  toxemia,
ethargy, or  alteration  of  consciousness.
Anemia:  (Hb  <  10  mg/dL)
Neutropenia  (absolute  neutrophil  count  [ANC]  <500
ells/mm3.13
Thrombocytopenia:  total  platelet  count  <  150.000/uL.13
Suspicion  of  invasive  bacterial  infection:  in  the  absence
f a  negative  culture,  the  following  clinical  criteria
ere observed:  clinical  or  laboratory  ﬁndings  of  sep-
is, or  hemodynamically  unstable  child  with  poor  general
tatus.
Proven invasive  bacterial  infection:  occurrence  of  bac-
eremia (one  or  more  positive  blood  cultures  for  bacterial
athogen). Sepsis  by  coagulase-negative  Staphylococcus
equires two  or  more  positive  blood  cultures  collected
n the  same  day;  probable  sepsis  is  indicated  if  there
re two  blood  cultures  for  coagulase-negative  Staphylo-
occus within  a  four-day  interval,  or  three  blood  cultures
ithin seven  days,  or  four  blood  cultures  within  ten
ays.
atient  selection  procedureshe  sample  size  required  for  the  study  (n  =  108  episodes
f respiratory  infection)  was  based  on  the  estimated  preva-
ence of  the  studied  viruses  obtained  from  the  review  of
t
g
a
ieveral  studies  (35%),  considering  a  sampling  error  of  9%  in
5% of  possible  samples.
Patients were  selected  consecutively  at  the  outpatient
linic of  HG,  from  Monday  through  Friday,  from  8:00  AM
o 5:00  PM,  and  from  the  hospital  admission  and  emer-
ency unit  of  the  Hospital  Universitário  on  the  other  days
nd times.  Fig.  1  shows  the  ﬂowchart  of  patient  selection,
nvestigation, and  follow-up  of  patients.
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Table  1  Total  number  and  percentage  of  major  types  of
cancer in  patients  with  ARI.  Grendacc  and  HUJ/Department
of Pediatrics,  Faculdade  de  Medicina  de  Jundiaí,  2012.
Oncologic  diagnosis  Frequency  %
ALL  42  40.0
HR-ALL 9  8.6
AML 4  3.8
NHL 4  3.8
HR-NHL 2  1.9
HL 3  2.9
Sarcomas 4  3.8
CNS 1  1.0
Neuroblastoma 1  1.0
Nephroblastoma 3  2.9
LCH 2  1.9
CML 3  2.9
Glioma 3  2.9
Osteosarcoma 17  16.2
Hemophagocytic sd. 3 2.9
Others 3  2.9
ALL, acute lymphoblastic leukemia; HR-ALL, high-risk acute
lymphoblastic leukemia; AML, acute myeloid leukemia; NHL,
non-Hodgkin lymphoma; HR-NHL, high-risk non-Hodgkin lym-
phoma;  HL, Hodgkin’s lymphoma; CNS, central nervous system;
LCH,  Langerhans cell histiocytosis; CML, chronic myeloid
leukemia; sd, syndrome.
Table  2  Distribution  of  respiratory  virus  types  in  positive
cases of  patients  with  ARI.  Grendacc  and  HUJ/Department
of Pediatrics  of  Faculdade  de  Medicina  de  Jundiaí,  2012.
Type  of  respiratory  virus %  n
Rhinovirus  23.1  24
Syncytial A/B  Virus  8.7  9
Metapneumovirus A/B  2.9  3
Inﬂuenza B  2.9  3
Coronavirus 229  2.9  3
Coronavirus 43  2.9  3
Inﬂuenza A  1.9  2
Coronavirus 63  1.0  1
Parainﬂuenza 2  1.0  1
Parainﬂuenza 3  1.0  1
Parainﬂuenza 4  1.0  1
Inﬂuenza A/H1N1  1.0  1
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Laboratory  investigation  for  respiratory  virus
detection
Samples  drawn  from  each  nostril  aspirate  and  one  from
nasopharyngeal swabs  were  obtained  from  all  patients
enrolled in  the  study,  in  the  supine  position  with  head
positioned on  the  midline.  At  the  time  of  collection,  the
sample swab  was  submitted  to  the  rapid  test  for  detection
of inﬂuenza  A,  H1N1,  and  B  (Inﬂuenza  H1N1  Pandemic  test,
Bioeasy, Brazil).  The  result  was  reported  immediately  to  the
physician for  treatment  decision.
Within  a  maximum  period  of  4  hours  after  collection,  the
samples were  mixed  and  added  to  a  Ringer  lactate  solu-
tion to  a  total  of  4  mL.  After  homogenization,  the  samples
(approximately 1  mL)  were  separated  into  aliquots  in  cry-
otubes, previously  identiﬁed  and  stored  in  liquid  nitrogen
and stored  at  -80 ◦C.  In  the  Pediatric  Infectious  Disease
Research Laboratory  of  the  FMJ,  the  DNA  and  total  RNA
nucleic acids  were  extracted  from  samples  using  the  extrac-
tion Kit  (RTP  DNA/  RNA  Virus  Mini  Kit,  Molecular,  STRATEC,
Germany).
The sensitivity  and  speciﬁcity  were  monitored  by
standard quality  control  for  molecular  diagnostics.  The  qual-
itative  detection  of  20  respiratory  viruses  (inﬂuenza  [A,
H1N1, and  B];  coronavirus  [NL63,  229E,  OC43,  and  HKU1];
parainﬂuenza [PIV1,  2,  3,  and  4];  rhinovirus  [HRV],  respi-
ratory syncytial  virus  [RSV  A/B];  human  metapneumovirus
[hMPV A/B];  adenovirus  [ADV];  enterovirus;  parechovirus;
and bocavirus  [hBoV])  was  performed  by  real-time  multi-
plex polymerase  chain  reaction  (FTD  -  Fast  Track  Diagnostics
- Belgium).
Bacteriological  Assessment
All  blood  cultures  (peripheral  and  central  samples)  were
performed using  the  kit  BACTEC/Alert  (BioMérieux  Inc.  -
United States).  Urinalysis  and  urine  culture  were  obtained
on admission,  as  well  as  other  cultures  from  different  sites,
if necessary.
Analysis of  peripheral  blood  was  performed  by  automated
hematology analyzer  (Sysmex®,  Model:  KX  21N,  USA)  within
2 hours  after  collection.
All laboratory  investigations  strictly  followed  the  manu-
facturers’ speciﬁcations.
Data  Analysis
Measures  of  central  tendency  and  dispersion  were  used  to
describe the  study  sample.  The  prevalence  of  viral  infections
with their  respective  95%  conﬁdence  interval  was  estimated.
To compare  proportions,  the  chi-squared  or  Fisher’s  exact
tests were  used.  The  software  used  was  SPSS,  release  17
(SPSS -  Chicago,  IL,  United  States).
ResultsA  total  of  48  patients  undergoing  cancer  treatment  agreed
to participate  in  the  study,  totaling  104  episodes  with  fever
and/or respiratory  symptoms.  The  median  age  was  12  ±
5.1 years,  and  the  youngest  patient  was  1  year  old.  The
o
v
(Total 100.0  104
ample  consisted  of  82  (78.8%)  male  children;  82  (78.8%)
ere white,  followed  by  17  mixed-race  (16.7%);  and  32  (31%)
atients were  from  the  city  of  Jundiaí.
ALL  was  the  most  prevalent  cancer,  identiﬁed  in  53
atients (51.9%,  p  =  0.043),  and  the  age  range  between  5
nd 8  years  was  the  most  frequent,  with  36  patients  (34.6%,
 =  0.046)  (Table  1).  Metastatic  disease  was  observed  in  23
ases, of  which  eight  (7.7%)  had  recurrence  of  the  underlying
isease.A respiratory  viral  pathogen  was  obtained  in  50%  (52/104)
f the  analyzed  cases  for  at  least  one  type  of  respiratory
irus. HRV  was  the  most  common  pathogen,  found  in  23.1%
24/105) of  infectious  episodes  (Table  2).
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Table  3  Cases  of  co-detection  of  more  than  one  respiratory
virus in  the  same  episode.
Case  Virus
2  HRV  +  AdVH
8  PI  2  +  CoV  229  +  CoV  43
15  HRV  +  hMPV  A/B
18  PI  4  +  SRV  A/B
21  HRV  +  EV  +  CoV  43
29  HRV  +  SRV  A/B
31  HRV  +  AdVH
HRV, human rhinovirus; AdVH, adenovirus; PI 2, Parainﬂuenza 2;
PI  4, Parainﬂuenza 4; CoV 229, coronavirus 229; CoV 43, coro-
navirus  43; EV, enterovirus; SRV A/B, syncytial respiratory virus
ﬂ
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patients with  cancer,  found  positive  results  for  6.4%  of  cases,A/B;  hMPV A/B, human metapneumovirus A/B.
The  analysis  of  104  samples  by  rapid  test  for  IFA  (indirect
uorescent antibody),  IFAH1N1,  and  IFB  (monoclonal  anti-
ody pools,  one  speciﬁc  for  type  A  inﬂuenza  viruses  and  one
peciﬁc for  type  B  inﬂuenza  viruses,  are  provided  for  use  in
FA assays)  resulted  in  six  samples  positive  for  inﬂuenza  virus
four inﬂuenza  A  and  two  inﬂuenza  B).
Regarding  the  number  of  viruses,  51  cases  (49%)  had  one
ype. The  number  of  cases  of  co-detection  of  respiratory
iruses was  17%  (18/104)  with  two,  and  3%  (3/104)  with
hree; the  most  frequently  observed  were  rhinovirus  and
oronavirus 43  (Table  3).
The  presence  of  fever  and  respiratory  virus  positivity  was
bserved in  17.6%  of  the  episodes  (p  =  0.332),  with  at  least
ne peak  of  fever  in  41  (39.4%),  and  respiratory  symptoms
n 53  (51%)  cases,  at  the  time  of  the  consultation.
Statistical  signiﬁcance  was  found  between  the  presence
f fever  and  severe  neutropenia  in  the  analyzed  episodes  (p
 0.001).
Among the  severe  neutropenic  cases,  30.7%  (4/13)  were
ositive for  some  type  of  respiratory  virus,  two  with  respi-
atory syncytial  virus  A  and  B,  one  with  coronavirus  229,  and
ne with  rhinovirus.  However,  when  considering  the  mild  to
oderate neutropenic  cases  (5.9%),  there  was  no  statistical
ssociation (p  =  0.169).  It  was  observed  that  the  majority  of
ases had  only  mild  respiratory  symptoms,  in  38.4%  (20/52).
Of  the  33  blood  cultures  collected,  three  (9.1%)  were  pos-
tive, and  the  bacterial  pathogens  associated  with  febrile
pisode were:  one  case  of  Klebsiella  pneumoniae,  one  case
f multi-resistant  Klebsiella  pneumoniae,  and  one  case  of
ram-negative bacilli.  Of  the  104  episodes  studied,  empiri-
al antibiotic  therapy  was  case  of  in  36  (34.2%)  cases.  Of  the
atients with  respiratory  viral  infection,  none  had  positive
lood or  urine  culture,  and  34.6%  (18/52)  received  antibiotic
herapy.
A total  of  102  episodes  were  analyzed  regarding  the
ematological characteristics,  with  leukopenia  observed  in
3.5% (24/102)  of  patients,  neutropenia  in  20.5%  (21/102),
nd severe  neutropenia  in  16.7%  (17/102),  of  which  52.9%  of
atients had  ALL.  Lymphopenia  was  present  in  41%  (42/102)
ases. It  was  also  observed  that  30.6%  (30/102)  of  patients
ad anemia  and  11.7%  (12/102)  had  thrombocytopenia.Although  it  was  observed  that  99%  (103/104)  of  patients
ad good  general  health  status,  hypothermia  was  observed
n 15%  (16/104)  and  anemia  in  43%  (44/104)  of  the  sample.
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nly  one  individual  had  a  clinical  picture  of  bacteremia;
owever, no  deaths  were  attributed  to  the  studied  episodes.
Regarding  the  epidemiology  of  the  ARI  episode,  it  was
bserved that  most  patients  had  no  previous  history  of
ontact with  ARIs  (8/104).  Although  not  statistically  signiﬁ-
ant (p  =  0.282),  the  correlations  between  the  total  number
f virus  positive  patients  versus  season  were  7.7%  (8/104)
or summer,  18.3%  (19/104)  for  spring,  32.7%  (34/104)  for
inter, and  41.3%  (43/104)  for  fall.
iscussion
any  concepts  of  viral  respiratory  diseases  in  healthy  chil-
ren during  infancy  have  been  recently  modiﬁed.14 In
atients with  cancer,  although  studies  in  the  last  decade
ave demonstrated  the  importance  of  ARIs,4--6 the  actual
ole of  these  infections  remains  unclear.
In  this  series  of  respiratory  infection  and/or  fever,  a
revalence of  respiratory  viruses  of  50%  was  observed,  show-
ng that  these  pathogens  were  the  most  often  detected
n ARIs  in  children  undergoing  chemotherapy.  The  ﬁndings
f this  study  are  consistent  with  those  in  the  litera-
ure, when  compared  with  studies  that  used  the  same
aboratory method  by  qPCR  technique.  Koskenvuo  et  al.4
ocumented  the  presence  of  respiratory  infection  in  44%  of
he cases  of  children  and  adolescents  with  leukemia  and
ever, and  Srinivasan  et  al.15 observed  rates  of  75%  in  their
tudy.
HRV was  the  most  common  viral  pathogen,  followed  by
oronavirus, RSV,  and  metapneumovirus,  demonstrating  the
mportance of  these  pathogens  in  the  studied  population.
ost studies  on  HRV  were  performed  in  immunosuppressed
atients after  bone  marrow  or  solid  organ  transplantation,
nd with  human  immunodeﬁciency  virus  (HIV)  carriers.16
lthough  there  is  increasing  evidence  of  the  possible  involve-
ent of  this  pathogen  in  lower  respiratory  tract  infections
n this  group,  the  pathogenesis  remains  unclear.
In  the  present  study,  the  clinical  picture  was  mild;  the
uthors did  not  observe  lower  respiratory  tract  infections
n patients  affected  by  this  type  of  virus  and  the  others,
lthough the  HRV  may  remain  in  the  airways  of  healthy
hildren after  resolution  of  acute  symptoms.  It  has  been
iscussed whether  direct  viral  damage  occurs,  or  if  there
s a  predisposition  to  secondary  invasion  with  worsening
f severity  and  clinical  prognosis.17 Other  authors  found  a
igher frequency  of  respiratory  viruses  for  SRV,  HRV,  PIV,  and
DV, although  the  clinical  aspects  have  been  little  explored
n publications.4,5 Torres  et  al.  reported  the  presence  of
1% SRV  and  of  23%  HRV,  with  only  episodes  of  fever  and
eutropenia.18
It  was  observed  that  PIV  was  present  in  3%  of  episodes,
ith serotypes  2,  3,  and  4  showing  similar  frequency,  con-
rary to  the  studies  in  which  PIV-3  has  been  the  most
revalent in  immunocompromised  children.  An  emphasis  on
ower airway  infection  and  increased  morbidity  and  mortal-
ty has  been  attributed  to  this  pathogen  in  recent  years.
Maeng  et  al.,19 in  a  retrospective  study  of  1,554  pediatricnd 54%  of  these  had  PIV,  with  mortality  of  18.5%,  whereas
rinivasan et  al.20 veriﬁed  that  complications  occurred  in
ower respiratory  tract  infection  in  young  children.
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RViral  respiratory  infections  in  cancer  patients  
The  epidemic  of  inﬂuenza  A/H1N1  raised  new  questions
about early  treatment  and  time  of  use  of  antiviral  drugs
based on  clinical  criteria  and  the  presence  of  risk  factors
for complications  from  the  disease,  such  as  immunosuppres-
sion. In  the  present  series,  antiviral  drugs  were  rarely  used
by pediatric  oncologists.  This  fact  might  be  explained  by  the
lack of  previous  experience  in  handling  these  drugs,  by  dis-
regarding the  importance  of  this  viral  pathogen  and  timely
access to  the  drugs  for  treatment  initiation.  The  impact  of
such a  measure  on  viral  resistance  to  drugs  in  children  with
cancer remains  unknown.
Other relevant  aspects,  such  as  the  impact  of  seasonal
inﬂuenza or  its  variants  in  children  with  cancer  are  not
well understood,  as  these  children  can  shed  the  virus  for
weeks or  months.21 In  a  study  involving  children  with  cancer
or children  undergoing  bone  marrow  transplantation,  Tran
et al.22 observed  infection  of  the  lower  airways  in  10%  of
cases of  inﬂuenza  A/H1N1;  however,  there  was  no  associ-
ation with  increased  mortality.  Further  investigations  with
children with  hematological  malignancies  have  also  rein-
forced this  observation,  although  there  was  an  increase  in
the number  of  hospitalizations,  chemotherapy  delay,  and
increased antimicrobial  use.  Deaths  were  rare  in  all  studies.
23--25
Infection  by  RSV  can  cause  death  in  approximately  1.1%  of
transplanted patients,  conﬁrming  the  impression  of  worsen-
ing of  cases  in  recent  years.  In  the  present  study,  the  patients
improved, and  there  were  no  deaths  or  complications
related to  RSV.  This  can  be  explained  in  part  by  greater
involvement of  patients  at  the  two-year  age  range,  in  which
these infections  are  less  severe.
Although  human  coronavirus  (hCoV)  is  recognized  as  a
common cause  of  infections  of  the  upper  respiratory  tract
and, to  a  lesser  extent,  in  the  lower  tract  of  immunocompe-
tent patients,  its  impact  is  unknown  in  immunocompromised
children.26
No  cases  of  bocavirus  were  observed,  contrary  to  ﬁndings
in the  literature.  This  fact  might  be  explained  by  the  non-
circulation of  this  pathogen  in  the  study  period,  limitations
of multiplex  molecular  identiﬁcation  methods,  or  character-
istics of  the  study  population.  The  real  role  of  this  virus  in
children with  cancer  is  unknown.
The  use  of  the  qPCR  technique27 allows  for  the  co-
detection of  more  than  one  virus  in  the  same  sample.
However, some  questions  need  further  clariﬁcation.  Does
it represent  a  coinfection,  co-detection,  or  asymptomatic
elimination? What  is  the  impact  of  co-detection  on  the  clin-
ical severity  of  respiratory  disease  in  patients  with  cancer?
The  co-detection  observed  in  the  present  study  was  17%
between HRV  and  hCoV.  Similar  rates  were  observed  in  stud-
ies in  children  without  immunosuppression,  14%  to  44%,  with
HRV being  the  second  or  third  most  frequent  virus.14 In  chil-
dren with  cancer,  Koskenvuo  et  al.4 found  a  co-detection
rate of  19.7%,  especially  between  HRV  and  RSV.  In  the
present cohort,  co-detection  was  not  associated  with  case
severity, as  the  initial  clinical  presentation  of  patients  was
mild, most  children  were  initially  in  good  general  health  sta-
tus, with  rare  complications  in  the  lower  airways,  and  there
were no  deaths.  De  Paulis  et  al.28 observed  no  impact  on
clinical severity  with  co-infection  in  hospitalized  infants.
In  contrast,  other  studies  also  carried  out  in  hospitalized
infants without  immunosuppression  showed  that  an  increase375
n  the  number  of  co-detections  may  result  in  increased  clin-
cal severity  in  young  children.14 This  fact  may  be  attributed
o the  accidental  ﬁnding  of  these  viruses  in  the  materi-
ls, without  important  clinical  signiﬁcance  in  the  severity
f cancer  patients  that  excrete  the  virus  for  long  periods.
A  viral  infection  may  increase  susceptibility  to  bacte-
ial co-infection.  In  a  multicenter  study  of  children  with
eukemia and  fever,  Koskenvuo  et  al.4 found  13%  bacterial
epsis in  patients  with  ARI.  In  a  study  of  febrile  neutrope-
ia, Avadhanula  et  al.29 found  an  association  with  bacterial
nfection in  one-third  of  cases,  suggesting  that  the  RSV
nfection can  increase  the  expression  of  receptors  for  Strep-
ococcus pneumoniae  and  Haemophilus  inﬂuenza  in  primary
ronchial epithelial  cells,  facilitating  bacterial  colonization
nd disease.
In the  present  study,  no  bacterial  complications  at  clinical
xamination were  observed,  with  favorable  outcome  simi-
ar to  those  patients  without  cancer.  The  authors  emphasize
he ﬁnding  of  hypothermia  in  15%  of  children,  but  without
rogression to  sepsis.  Blood  cultures  were  positive  in  only
.1% of  cases,  similar  to  other  studies.18,30
Therefore,  the  detection  of  a  viral  pathogen  may  provide
he physician  with  a  safer  therapeutic  approach,  appropri-
te antimicrobial  use,  reducing  unnecessary  costs  imposed
n the  health  system,  and  providing  direct  improvement  in
orbidity and  mortality  of  children  with  cancer.
Although  seasonality  for  respiratory  viruses  showed  more
revalence in  the  fall  and  winter,  it  was  observed  that  this
attern was  not  homogeneous  for  all  studied  viruses,  and  a
onger period  of  observation  would  be  necessary  to  establish
 seasonal  pattern  for  this  group  of  children.
Respiratory  viruses  are  pathogens  found  in  most  pediatric
ancer patients  receiving  chemotherapy,  demonstrating  that
heir presence  may  be  a  causative  factor  for  the  infec-
ious episode.  Their  co-detections  were  frequent  in  cancer
atients with  ARI.  It  was  not  possible  to  identify  whether
he severe  acute  infection  was  directly  related  to  the  type
f cancer  or  viral  pathogen.
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